Inventor
ASCULAI SAMUEL S
CA26 patents
⚠️ This page may combine multiple inventors who share the name “ASCULAI SAMUEL S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HYAL PHARMA CORP
14 patentsUS6069135AMay 30, 2000
Use of hyaluronic acid or its derivatives to enhance delivery of therapeutic agents
HYAL PHARMA CORP87 citations99
US6194392B1Feb 27, 2001
Treatment of conditions and disease
HYAL PHARMA CORP41 citations96
US6048844AApr 11, 2000
Treatment of conditions and disease
HYAL PHARMA CORP54 citations96
US5985851ANov 16, 1999
Use of hyaluronic acid or its derivatives in peritoneal dialysis and formulations thereof
HYAL PHARMA CORP25 citations96
US5929048AJul 27, 1999
Treatment of conditions and disease
HYAL PHARMA CORP34 citations96
US5914314AJun 22, 1999
Use of a form of hyaluronic acid and a medicinal agent for reducing rejection of organs transplantation in mammals
HYAL PHARMA CORP21 citations96
US5852002ADec 22, 1998
Treatment of conditions and disease
HYAL PHARMA CORP46 citations96
US5830882ANov 3, 1998
Compositions containing a form of hyaluronic acid and a medicinal agent for treating acne in mammals and methods for administration of such composition
HYAL PHARMA CORP34 citations96
US5827834AOct 27, 1998
Method of using hyaluronic acid or its pharmaceutically acceptable salts for the treatment of disease
HYAL PHARMA CORP54 citations96
US5811410ASep 22, 1998
Method of administering of a hyaluronic acid and an NSAID to decrease side effects of the NSAID
HYAL PHARMA CORP49 citations96
US5932560AAug 3, 1999
Treatment of conditions and disease
HYAL PHARMA CORP20 citations92
US5614506AMar 25, 1997
Use of hyaluronic acid and forms to prevent arterial restenosis
HYAL PHARMA CORP26 citations91
US6147059ANov 14, 2000
Formulations containing hyaluronic acid
HYAL PHARMA CORP24 citations90
US6087344AJul 11, 2000
Formulations containing hyaluronic acid
HYAL PHARMA CORP15 citations71
MONSANTO CO
3 patentsUS4299814ANov 10, 1981
Radioimmunoassay of MIF
MONSANTO CO56 citations91
US4309413AJan 5, 1982
Method of producing immune response by administering polymeric composition
MONSANTO CO16 citations73
US4255537AMar 10, 1981
Polymeric immunoregulatory agents containing half-amide/half carboxy/imide groups
MONSANTO CO14 citations73